• Korean Circulation Journal
• /
• 제53권12호
• /
• pp.840-842
• /
• 2023

• Bulletin of the Korean Chemical Society
• /
• 제35권1호
• /
• pp.158-164
• /
• 2014

Substance P and neuropeptide Y were discovered as early diagnostic biomarkers of acute myocardial infarction in Korean patients and confirmed using enzyme-linked immunosorbent assay (ELISA). We screened 12 peptides from the sera of Korean acute myocardial infarction (AMI) patients and detected 3 peptides (neuropeptide Y, substance P, and N-terminal pro-B-type natriuretic peptide) to be elevated from patients' sera by liquid chromatography mass/mass spectrometry. The elevated concentration of 3 peptides was confirmed by ELISA. The screening results revealed the substance P, neuropeptide Y, and pro-B-type natriuretic peptide (47-76) concentrations were higher in patients' sera than in healthy controls. The sensitivity and specificity of substance P for AMI diagnostic marker were 80% and 83%, respectively, and those of neuropeptide Y were 87% and 90%, respectively compared to healthy controls. These results suggest that substance P and neuropeptide Y could be used as early diagnostic biomarkers in patients with AMI.

• BMB Reports
• /
• 제56권6호
• /
• pp.341-346
• /
• 2023

Acute myocardial infarction (AMI) is a multifaceted syndrome influenced by the functions of various extrinsic and intrinsic pathways and pathological processes, which can be detected in circulation using biomarkers. In this study, we investigated the secretome protein profile of induced-hypertrophy cardiomyocytes to identify next-generation biomarkers for AMI diagnosis and management. Hypertrophy was successfully induced in immortalized human cardiomyocytes (T0445) by 200 nM ET-1 and 1 μM Ang II. The protein profiles of hypertrophied cardiomyocyte secretomes were analyzed by nano-liquid chromatography with tandem mass spectrometry and differentially expressed proteins that have been identified by Ingenuity Pathway Analysis. The levels of 32 proteins increased significantly (>1.4 fold), whereas 17 proteins (<0.5 fold) showed a rapid decrease in expression. Proteomic analysis showed significant upregulation of six 14-3-3 protein isoforms in hypertrophied cardiomyocytes compared to those in control cells. Multi-reaction monitoring results of human plasma samples showed that 14-3-3 protein-zeta levels were significantly elevated in patients with AMI compared to those of healthy controls. These findings elucidated the role of 14-3-3 protein-zeta in cardiac hypertrophy and cardiovascular disorders and demonstrated its potential as a novel biomarker and therapeutic strategy.

• 한국광학회지
• /
• 제30권2호
• /
• pp.59-66
• /
• 2019

$2^{\circ}$ 기울어진 산화막 코팅 실리콘 기판의 바이오칩과 프리즘으로 제작한 바이오센서와 검광자 회전 타원편광계를 이용하여 심근경색 생체표지자인 미오글로빈과 cTnI의 진단 농도를 수백 초 내에 실시간 초고감도로 측정하는데 성공하였다. 러닝 버퍼로는 순수한 phosphate buffered saline (PBS) 또는 PBS에 10% 인간 혈청을 섞은 러닝 버퍼를 사용하였다. PBS 조건에서는 미오글로빈과 cTnI가 각각 1 ng/mL와 5 pg/mL로 측정되었으며, PBS에 인간 혈청을 10% 섞은 조건에서는 미오글로빈과 cTnI는 각각 1 ng/mL과 1 pg/mL로 측정되었다. 이러한 심근경색 생체표지자의 진단 농도는 현재 제시된 세계보건기구의 심근경색 진단 기준 농도보다 미오글로빈은 1/15배 낮고, cTnI는 1/80배 낮다.

• Biomolecules & Therapeutics
• /
• 제24권1호
• /
• pp.19-24
• /
• 2016

Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality worldwide. The exploration of new biomarkers with high sensitivity and specificity for early diagnosis of AMI therefore becomes one of the primary task. In the current study, we aim to detect whether there is any heart specific long noncoding RNA (lncRNA) releasing into the circulation during AMI, and explore its function in the neonatal rat cardiac myocytes injury induced by $H_2O_2$. Our results revealed that the cardiac-specific lncRNA MHRT (Myosin Heavy Chain Associated RNA Transcripts) was significantly elevated in the blood from AMI patients compared with the healthy control ($^*p<0.05$). Using an in vitro neonatal rat cardiac myocytes injury model, we demonstrated that lncRNA MHRT was upregulated in the cardiac myocytes after treatment with hydrogen peroxide ($H_2O_2$) via real-time RT-PCR (qRT-PCR). Furthermore, we knockdowned the MHRT gene by siRNA to confirm its roles in the $H_2O_2$-induced cardiac cell apoptosis, and found that knockdown of MHRT led to significant more apoptotic cells than the non-target control ($^{**}p<0.01$), indicating that the lncRNA MHRT is a protective factor for cardiomyocyte and the plasma concentration of MHRT may serve as a biomarker for myocardial infarction diagnosis in humans AMI.

• 한국임상수의학회지
• /
• 제29권2호
• /
• pp.148-153
• /
• 2012

Atrial natriuretic peptide (ANP)은 여러 가지 다양한 심근질환과 연관성이 있는 것으로 알려져 있으나 심근경색에서 ANP의 변화에 대해서는 명확하게 밝혀져 있지 않다. 따라서 본 연구에서는 흰쥐 심근경색 모델을 활용하여 혈장내 ANP의 변화를 살펴보아 심근경색에서 ANP의 역할을 규명해보고자 하였다. 수컷 흰쥐 60일령에서 왼심장동맥을 결찰 하여 심근경색 모델을 만들었고 개흉하여 sham 대조군을 삼았다. 각각의 실험군과 대조군을 수술 후 1, 3, 6, 12, 18시간과 1, 3, 5, 7, 14 및 30일에 희생시켜 실험에 사용하였다. 심근경색의 크기는 planimetry와 perimetry법을 적용하여 측정하였고 혈장내 ANP 농도는 방사면역측정법을 적용하여 측정하였다. 왼심장동맥을 결찰한 실험군에서 평균 심근경색의 크기는 왼심실의 39.6-44.5%이었고 유의성 있는 차이는 없었다. 혈장내 ANP 농도는 심근경색 후 1, 3, 6, 12, 18 및 24시간에 대조군에 비하여 명확하게 증가하였으나 3, 5, 7, 14 및 30일령에서 ANP 농도는 대조군에 비하여 유의성 있는 차이를 나타내지 않았다. 이러한 결과는 수컷 흰쥐에서 혈장내 ANP 농도는 심근경색 초기에 명확하게 증가함을 입증하였고 급성심근경색의 진단을 위한 생체표지인자로 이용할 수 있는 가능성을 제시해주고 있다.